AXGN

AxoGen Inc.

Price

$51.35

return (12m)

116.03%

p/e

-77.70

p/bv

10.17

DIVIDEND YIELD

0.00%

AXGN price

AxoGen

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment AXGN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

41.09%

3 months

14.57%

1 year

116.03%

2 years

261.62%

5 years

258.59%

10 years

558.33%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AXGN

Valuation

P/E

-77.70

Sector 0.83

Industry 3.15

P/BV

10.17

Sector 1.76

Industry 1.95

P/Revenue (PSR)

10.38

Sector 1.46

Industry 1.56

EV/EBITDA

-122.85

Sector -49.53

Industry -2.83

EV/EBIT

-84.87

Sector -44.05

Industry -0.77

P/EBITDA

-128.44

Sector -31.35

Industry -50.28

P/EBIT

-88.73

Sector -29.48

Industry -34.80

P/Total Assets

8.55

Sector 0.80

Industry 0.86

P/Net Current Assets

17.18

Sector -24.28

Industry -9.30

P/Working Capital

15.33

Sector 2.46

Industry 0.83

EPS

-0.63

Sector -0.70

Industry -0.60

BVPS

4.80

Sector 4.35

Industry 4.37

Efficiency

Gross Margin

74.56%

Sector 49.06%

Industry 50.68%

EBITDA Margin

0.91%

Sector -236.78%

Industry -51.99%

EBIT Margin

-5.12%

Sector -19.73%

Industry -25.80%

Net Profit Margins

-13.36%

Sector -23.90%

Industry -29.17%

Asset Turnover

0.23

Sector 0.13

Industry 0.15

Profitability

ROE

-18.21%

Sector -27.98%

Industry -32.74%

ROA

-13.15%

Sector -23.76%

Industry -24.29%

ROIC

-5.31%

Sector -477.42%

Industry -92.34%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.60

Sector 1.92

Industry 2.00

Net Debt / EBITDA

5.59

Sector -21.38

Industry -2.49

Net Debt / EBIT

3.86

Sector -6.88

Industry -1.97

Net Debt / Equity

-0.44

Sector -0.58

Industry -0.31

Gross Debt / Equity

0.00

Sector -0.69

Industry 0.14

Equity/Assets

0.84

Sector 0.46

Industry 0.46

Liabilities/Assets

0.16

Sector 0.49

Industry 0.51

Growth

5Y Revenue CAGR

14.55%

Sector -

Industry -

5Y Earnings CAGR

4.45%

Sector -

Industry -

Fundamentals AXGN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AXGN AxoGen Inc.	$51.35	120.86%	0.00%	-77.70	10.17	-18.21%	-13.36%
ABT Abbott Laboratories	$115.51	-4.52%	2.35%	32.98	0.00	-%	11.52%
MDT Medtronic PLC	$104.96	20.21%	2.94%	23.79	2.45	10.57%	13.93%
BSX Boston Scientific Corp.	$45.82	-53.64%	0.00%	16.22	0.00	-%	18.14%
TMDX TransMedics Group Inc.	$72.76	-41.67%	0.00%	14.93	4.37	36.28%	22.69%
IDXX IDEXX Laboratories Inc.	$698.55	-3.37%	0.00%	39.02	27.58	74.21%	25.03%
RMD ResMed Inc.	$240.51	-2.37%	1.05%	22.29	5.15	24.27%	26.94%
COHR Coherent Inc.	$195.09	47.80%	0.00%	50.22	3.60	9.34%	11.31%
SYK Stryker Corp.	$339.65	-4.12%	1.19%	30.45	4.73	16.51%	14.43%
PHG Koninklijke Philips NV	$31.06	18.65%	3.75%	19.94	1.95	10.27%	6.30%
INMD InMode Ltd.	$14.20	-3.34%	0.00%	10.14	1.25	12.33%	20.69%
BDX Becton Dickinson and Company	$209.19	20.92%	2.11%	58.03	2.24	3.77%	6.29%
DXCM DexCom Inc.	$88.48	46.42%	0.00%	32.11	12.25	38.49%	20.12%
EW Edwards Lifesciences Corp.	$99.37	19.62%	0.00%	53.52	5.01	9.42%	15.43%
ALGN Align Technology Inc.	$164.90	21.54%	0.00%	25.77	2.52	10.16%	9.99%
SNN Smith & Nephew PLC	$32.46	-8.61%	2.61%	22.28	4.84	21.74%	9.20%
IRMD iRadimed Corporation	$88.58	6.52%	1.62%	43.53	9.86	23.52%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$110.15	11.47%	1.00%	22.78	1.45	6.41%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AXGN - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/27/2010	02/12/2010	1.00000000
Dividends	02/23/2005	03/11/2005	0.05050000

ABOUT AxoGen

AxoGen Inc.

Average Investor10 user rating

4.0 (2 people)

United States

24 years

Founded: 2002

2010

Time since IPO - 16 years

622

Employees

AxoGen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.61 billion, with shareholders equity totaling $256.26 million.

The company employs approximately 622 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, AxoGen Inc. reported $251.17 million in revenue, generating net income of $-33.55 million.

Key financial metrics include a P/E ratio of -77.70, a price-to-book (P/B) ratio of 10.17, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AXGN.

Market cap

$2.61 billion

Net worth

$256.26 million

$256,257,000.00

Assets

$304.86 million

$304,863,000.00

Total Shares Outstanding

53.34 million

53,339,000

Average Daily Trading Volume

$1.53 million

$1,532,826.00

Sector

Health

Industry

Medical Supplies and Equipment

AXGN

AXGN revenue and profits

Financial Results AXGN

DRAG THE FRAME TO SEE MORE DATA

AXGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$79.96 4,91% (12M)

P/E

23.54

3.70%

ROE

6.21%

P/BV

1.44

CI - Cigna

$305.41 20,31% (12M)

P/E

11.53

2.07%

ROE

16.51%

P/BV

1.85

CNC - Centene

$76.01 106,32% (12M)

P/E

-6.50

0.00%

ROE

-20.35%

P/BV

1.46

HUM - Humana

$417.42 59,97% (12M)

P/E

38.53

0.65%

ROE

6.81%

P/BV

2.56

SNY - Sanofi

$47.47 0,70% (12M)

P/E

4.18

3.96%

ROE

18.43%

P/BV

0.77

JNJ - Johnson & Johnson

$276.32 52,71% (12M)

P/E

41.75

1.92%

ROE

20.02%

P/BV

8.24

LLY - Eli Lilly

$1,417.99 54,32% (12M)

P/E

46.01

0.47%

ROE

86.09%

P/BV

31.51

HCA - HCA Healthcare

$510.70 8,67% (12M)

P/E

14.99

0.65%

ROE

-132.40%

P/BV

-12.58